NEW once-daily GLP-1 pill that you can take with or without food, with no fasting required. Awaiting UK approval, with The Independent Pharmacy expecting to be among the early providers.
Foundayo (Orforglipron) GLP-1 Pill
Unavailable
- Daily GLP-1 treatment, without injections
- Skip the fasting, fridge and sharps bins
- Lose an average of 12.4% at the highest dose*
- May help quiet hunger and make less feel like enough
Foundayo (Orforglipron): What You Need to Know
Your day, meals and plans will not always follow a perfect schedule. That’s where the flexibility of Foundayo may make a difference. It’s a once-daily GLP-1 weight loss treatment designed to fit around your life, not make you rearrange it.
So, what could that look like for you? Developed by the team behind the Mounjaro injection, Foundayo contains the active ingredient orforglipron. As with the Wegovy pill, it may mean less food noise pulling your attention back to what to eat next. That leaves you with more headspace to focus on the habits that help you feel healthier, stronger and more in control, while supporting lasting weight loss and your overall health.
If approved, you may be able to access Foundayo through regulated UK pharmacies, including The Independent Pharmacy, following a quick online consultation and clinical assessment. Simple, supported and without the waiting rooms or queues.
You’ll also have our expert clinical team on your side, with tailored advice and ongoing support to help you stay confident, keep your momentum and make progress that feels built to last.
*Based on people who continued treatment as intended in the 72-week ATTAIN-1 trial, alongside exercise and a healthy, balanced diet. Individual results may vary.
Who Is Foundayo (Orforglipron) Suitable For?
Suitable for pregnancy?No
Suitable for breastfeeding?No
Consultation required?Yes
Foundayo (Orforglipron) Summary
- Fast, discreet delivery
- 100% UK-based pharmacy
- Free advice and support
- We're rated 4.9 out of 5
Based on over 30,000 reviews collected on Google and Reviews.io.
Foundayo (Orforglipron) GLP-1 Pill Information
When Will Foundayo (Orforglipron) Be Available in the UK?
So, how long might you have to wait for Foundayo?
Right now, Foundayo is not approved or available to buy in the UK. Before it can be prescribed here, it must be reviewed and authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).
There is no confirmed UK launch date or pricing yet, but we’re already preparing for its potential arrival.
As soon as more information is confirmed, you’ll find it here, including the latest on approval, pricing, eligibility and how you may be able to access Foundayo through The Independent Pharmacy.
No chasing updates across the internet. Just clear, confirmed information in one place, so you know exactly where you stand.
What Is Foundayo (Orforglipron)?
So, is Foundayo simply another GLP-1 with a different name? Yes and no.
Yes, Foundayo (orforglipron) is a prescription weight loss treatment that works on the same GLP-1 pathway as Wegovy, Ozempic and Mounjaro injections. It helps regulate appetite and is taken as a once-daily tablet, offering an alternative to weekly injections.
But no, it is not simply an injectable GLP-1 squeezed into pill form. Peptide-based treatments are made from small chains of proteins, which can break down in the stomach. That is why oral options such as the Wegovy pill need an absorption enhancer called SNAC to help protect the medicine and get it through the stomach lining. It’s also why they come with specific fasting, food and drink rules.
Orforglipron works differently. It’s a small-molecule, non-peptide treatment, with around 79% of each oral dose reaching the bloodstream on average, and it doesn’t require an added absorption enhancer. In practical terms, that means it can be taken with or without food, at a time that fits your routine.
Foundayo (Orforglipron) vs Mounjaro Injections: Comparison
Choosing between Foundayo and Mounjaro isn’t only about how you take them. It’s also about how they work and the level of weight loss you’re hoping to achieve.
Mounjaro injections target two hormones, GLP-1 and GIP, and they produced greater average weight loss in clinical trials. Foundayo targets GLP-1 alone and comes as a once-daily pill, which you may feel is easier to fit into your routine.
Would you rather remember one injection each week or take a pill every day? The table below compares the practical and clinical differences to help you decide which option may suit you best.
| Feature | Foundayo Tablet | Mounjaro Injections |
|---|---|---|
| Active ingredient | Orforglipron | Tirzepatide |
| Type of treatment | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
| How it works | Helps regulate appetite, increasing fullness and reducing hunger and food cravings | Helps regulate appetite, increasing fullness and reducing hunger and food cravings |
| How often you use it | Once a day | Once a week |
| Available strengths | 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg, 17.2mg | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
| Standard starting dose | 0.8mg once a day | 2.5mg once a week |
| Common side effects | Nausea, diarrhoea, vomiting, constipation, abdominal pain, indigestion | Nausea, diarrhoea, vomiting, constipation, abdominal pain, indigestion |
| Weight loss in studies | 11.2% average weight loss over 72 weeks¹ | 22.5% average weight loss over 72 weeks³ |
| Approved for weight loss in the UK? | No | Yes |
How Does Foundayo (Orforglipron) Work?
Hunger and fullness are shaped by signals travelling between your gut and your brain. GLP-1 plays an important part in that conversation.
Your body naturally releases GLP-1 after you eat, helping to regulate your appetite and signal when you have had enough. Foundayo keeps those signals active for longer, which may help you:
- Feel less hungry by reducing hunger signals in the brain
- Feel satisfied with smaller portions
- Stay fuller for longer by slowing how quickly food leaves your stomach
- Maintain steadier blood sugar levels, which may also help with appetite control
The aim is not to switch off hunger completely. Hunger signals are a normal way for your body to tell you it needs food. Foundayo may simply make those signals easier to manage, so they don’t call all the shots.
Foundayo (Orforglipron) Effectiveness
When you’re choosing a weight loss treatment, clinical results matter. They help you understand what you might achieve and whether Foundayo is an option worth considering.
In a 72-week clinical trial, adults living with overweight or obesity taking the highest dose of orforglipron lost an average of 12.4% of their starting body weight.¹
In people with type 2 diabetes, average weight loss was lower, typically around 5–10%. This is similar to the results seen with other GLP-1 treatments.
How To Use Foundayo (Orforglipron)
- Swallow tablets whole. Do not crush, break or chew the tablet.
- Take 1 pill a day.
- Foundayo can be taken with or without food or water.
How To Store Foundayo (Orforglipron)
- Store at room temperature at 20°C–25°C.
- Foundayo (Orforglipron) is sensitive to light. Protect Foundayo (Orforglipron) from light by keeping it in the original box.
- Keep Foundayo (Orforglipron) out of the reach of children.
Foundayo (Orforglipron) Ingredients
Active ingredient: orforglipron
Other ingredients: copovidone, crospovidone, magnesium stearate, microcrystalline cellulose and sodium carbonate anhydrous.
For the most up-to-date list of ingredients, please check the Patient Information Leaflet inside the box.
Foundayo (Orforglipron) Side Effects
Like many medications, Foundayo (Orforglipron) may cause side effects. These can include:
- Nausea
- Constipation
- Diarrhoea
- Vomiting
- Abdominal pain
- Fatigue
- Gastroesophageal reflux disease (GERD)
- Indigestion
Be sure to inform your prescriber of any concerns or side effects you experience.
If you do have any side effects, want to prepare for starting orforglipron or increasing your dose, our unique GLP-1 Side Effects Treatment Pack may help.
Foundayo (Orforglipron) Warnings
Please read the following warnings carefully before use.
- Do not use Foundayo (Orforglipron) if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome.
- Do not use Foundayo (Orforglipron) if you’re allergic to orforglipron or any of the other ingredients in Foundayo (Orforglipron).
- In animal studies, GLP-1 medicines have been associated with thyroid tumours. It is not known if this applies to humans. Tell your healthcare professional if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Important: Foundayo (Orforglipron) may reduce the effectiveness of oral contraceptives. Additional barrier contraception, such as condoms, is recommended.
This treatment may not be suitable for all patients, including some older adults or those with complex health conditions.
For a full list of warnings and side effects, please see the Patient Information Leaflet.
Why Choose The Independent Pharmacy?
Deciding on the right treatment can feel overwhelming. That's why our experienced UK-based clinical team is here to answer your questions and help you make informed decisions about your health.
When you choose The Independent Pharmacy, you can expect:
- Unlimited expert support if you have questions about your treatment
- Trusted advice from our UK-based clinical team
- Confidence in a UK-regulated pharmacy you can rely on
- Peace of mind that you're receiving genuine products
- Convenient, discreet delivery directly to your door
Orforglipron (Foundayo) FAQs
When is orforglipron (Foundayo) going to be available in the UK?
Orforglipron (Foundayo) is expected to be available later this year in the UK, although timelines may change. Orforglipron (Foundayo) has been approved for use in the US, but is still awaiting UK approval by the MHRA.
Where can I buy orforglipron (Foundayo) in the UK?
Orforglipron (Foundayo) is not yet available to buy in the UK as it’s waiting on approval from the MHRA. Once approved, it’s likely to be available at regulated pharmacies, including The Independent Pharmacy.
How much will orforglipron (Foundayo) cost?
In the US, where orforglipron is sold under the brand name Foundayo, the cost varies depending on insurance and dosage.
UK pricing will be confirmed if and when the treatment is approved.
Does orforglipron (Foundayo) cost more than Mounjaro injections?
We don’t yet know how much orforglipron (Foundayo) will cost in the UK.
Final pricing will be confirmed once it’s approved and available.
What is the difference between orforglipron (Foundayo) and the Mounjaro injections?
Orforglipron (Foundayo) is a daily tablet that works on the GLP-1 pathway to reduce appetite, while Mounjaro is a weekly injection that targets both GLP-1 and GIP, making it more potent. Both help control hunger and support weight loss, but Mounjaro typically leads to greater results overall.
In studies, orforglipron (Foundayo) shows 11.2% average weight loss¹, compared to 22.5% with Mounjaro³,though orforglipron (Foundayo) offers the convenience of a daily pill without injections.
Is orforglipron (Foundayo) as effective as GLP-1 injections?
Orforglipron (Foundayo) is a more convenient option than GLP-1 injections, but is not as clinically effective as GLP-1 injections.
Foundayo Tablet
Wegovy Injection
Mounjaro Injection
Weight loss results over 72 weeks
11.2%¹
20.7%⁴
22.5%³
Who is eligible for orforglipron (Foundayo)?
If approved in the UK, orforglipron (Foundayo) may be prescribed to adults:
- With a BMI of 30 or above
- With a BMI of 27 or above and a related health condition (such as high blood pressure or type 2 diabetes)
What orforglipron (Foundayo) dosages and strengths are available?
Orforglipron (Foundayo) is available in the current strengths:
- 0.8mg
- 2.5mg
- 5.5mg
- 9mg
- 14.5mg
- 17.2mg
How do I switch from injections to orforglipron (Foundayo)?
If you wish to switch from weight loss injections to orforglipron (Foundayo), you need to do so under clinical supervision.
When orforglipron (Foundayo) becomes available, speak to our UK-registered pharmacists about making the transition safely.
What if I miss a dose of orforglipron (Foundayo)?
If you miss a dose of orforglipron (Foundayo), take the missed dose as soon as you remember. If it’s been longer than a day, skip that dose and take the next day’s dose as normal.
Is orforglipron (Foundayo) effective for weight loss in non-diabetics?
Yes, orforglipron (Foundayo) is effective for weight loss in non-diabetics. The ATTAIN-1 clinical trial demonstrated that orforglipron (Foundayo) produced an average weight loss of 11.2% in non-diabetics.¹
What happens if you take too much orforglipron (Foundayo)?
If you take more orforglipron (Foundayo) than you’ve been prescribed, you should seek medical advice as soon as possible.
If you experience severe symptoms, seek medical advice immediately.
What should I avoid while using orforglipron (Foundayo)?
Avoid eating greasy, rich or high-fat food when using orforglipron (Foundayo). It works best with a healthy balanced diet and increased physical activity.
Orforglipron key takeaways
Orforglipron (Foundayo) is a weight loss treatment that offers a convenient alternative to injections. As a once-daily tablet with no food or timing restrictions, it may suit people looking for a simpler way to manage their weight alongside a healthy diet and lifestyle.
While it has shown promising results in clinical trials, it’s not yet approved for use in the UK. Once available, it will require a prescription and clinical assessment to ensure it’s safe and suitable for you.
If you’re exploring weight loss treatment options, you can start an online consultation with our UK-registered clinicians. They’ll assess your needs and help you choose the most appropriate treatment for you.
We’re a Fully Regulated Online Pharmacy
As a UK-based pharmacy, we follow the same strict regulatory standards as any physical pharmacy. Our expert clinical team and services are overseen by multiple regulatory bodies to ensure your care is always safe, secure and confidential.
- View Our GPhC Registration
View Our CQC RegistrationCare Quality Commission (CQC)
Visit The GMC WebsiteGeneral Medical Council (GMC)
View Our NHS ListingNHS Prescriptions
Visit The NPA WebsiteNational Pharmacy Association (NPA)
View The DiCE NetworkDigital Clinical Excellence (DiCE)
Test Our LegitScript CertificationLegitScript
View Our CertificationNCSC Cyber Essentials
Search For Our ListingLiving Wage Employer
Run by experienced healthcare professionals
We think accessing healthcare should be easy. Whether we’re fulfilling NHS prescriptions or helping people find the right treatments, we aim to offer our customers dependable, economical and convenient access to medicines with a personal and discreet service.
Related Treatments
- New product
Wegovy Pill (Semaglutide Tablet)
Wegovy Pill£128.99 - Best seller
Mounjaro 2.5mg - 15mg Injections
Mounjaro Weight Loss Injections£179.99 - Best seller
Wegovy 0.25mg - 7.2mg Injections
Wegovy Weight Loss Injections 0.25mg - 7.2mg£99.79 - Best seller
Orlistat 120mg Capsules
Orlistat 120mg Capsules£29.89
We stock 14 other treatments for Weight Loss
Visit our Weight Loss page for treatments, advice and FAQs.
Ordering as easy as 1, 2, 3
1. Find the ideal treatment
2. Get a free consultation
3. Enjoy speedy delivery
- References
- 1. Wharton S et al, Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
- 2. FDA Approves First New Molecular Entity Under National Priority Voucher Program
- 3. Jastrebof, Ania M, et al, Tirzepatide Once Weekly for the Treatment of Obesity
- 4. Wharton S, et al, Once-weekly semaglutide 7.2mg in adults with obesity (STEP UP)
- 5. Knop FK, et al. Oral semaglutide 50mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
- 6. Prof Horn et all, Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial